STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 64 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,876,000 | +15.7% | 1,595,082 | 0.0% | 0.18% | -25.3% |
| Q3 2020 | $3,350,000 | +93.1% | 1,595,082 | +247.5% | 0.24% | +76.3% |
| Q2 2020 | $1,735,000 | -0.1% | 458,971 | -50.0% | 0.14% | +36.3% |
| Q1 2020 | $1,736,000 | +36.4% | 917,942 | +50.7% | 0.10% | -30.1% |
| Q4 2019 | $1,273,000 | -42.3% | 608,971 | -34.1% | 0.15% | -40.7% |
| Q3 2019 | $2,208,000 | -23.6% | 923,700 | 0.0% | 0.25% | -6.5% |
| Q2 2019 | $2,891,000 | -31.6% | 923,700 | +8.8% | 0.26% | -31.3% |
| Q1 2019 | $4,227,000 | +11.2% | 848,700 | 0.0% | 0.38% | +66.5% |
| Q4 2018 | $3,802,000 | +161.5% | 848,700 | +183.2% | 0.23% | +144.7% |
| Q3 2018 | $1,454,000 | -3.1% | 299,700 | +19.9% | 0.09% | -6.9% |
| Q2 2018 | $1,500,000 | -32.2% | 250,000 | 0.0% | 0.10% | -48.5% |
| Q1 2018 | $2,213,000 | +52.6% | 250,000 | +25.0% | 0.20% | +60.7% |
| Q4 2017 | $1,450,000 | – | 200,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 8,083,442 | $22,310,000 | 14.49% |
| AIGH Capital Management LLC | 2,194,173 | $6,056,000 | 1.27% |
| Worth Venture Partners, LLC | 550,196 | $1,519,000 | 0.74% |
| Stonepine Capital Management, LLC | 445,701 | $1,230,000 | 0.66% |
| NEA Management Company, LLC | 4,141,308 | $11,430,000 | 0.26% |
| Ikarian Capital, LLC | 1,160,450 | $3,203,000 | 0.11% |
| ALGERT GLOBAL LLC | 99,397 | $274,000 | 0.09% |
| Zebra Capital Management LLC | 24,039 | $66,000 | 0.07% |
| HighVista Strategies LLC | 28,432 | $79,000 | 0.06% |
| Orbimed Advisors | 1,744,669 | $4,815,000 | 0.04% |